STOCK TITAN

Revenue jumps at Garden Stage (Nasdaq: GSIW) while net loss grows

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Garden Stage Limited reported strong top-line growth but deeper losses for the first half of fiscal 2026. Revenue jumped to US$3.4 million from US$0.7 million, driven by higher brokerage commissions, introducing and referral income, underwriting and placement fees, and new advisory and investment management mandates. However, expenses rose sharply to US$9.9 million, with particularly large increases in professional fees, technology, and travel and business development.

Net loss nearly doubled to US$6.5 million from US$3.3 million, although loss per share improved to US$0.11 as the share count expanded. The company raised about US$14.8 million from issuing ordinary shares, lifting cash and restricted cash to US$19.0 million as of September 30, 2025. It also agreed to acquire Mental Form (BVI) Limited for US$10.7 million and signed a January 2026 private placement for 47,961,831 Class A shares at US$0.1251 per share, targeting roughly US$6.0 million in gross proceeds. Shareholders approved a move to a dual-class structure with high-vote Class B shares.

Positive

  • Revenue growth: Total revenues rose 382.9% year over year to US$3,401,178 for the six months ended September 30, 2025, with strong increases across most service lines.
  • Improved liquidity: The company raised approximately US$14,752,687 from issuing ordinary shares, increasing total cash and restricted cash to US$18,961,800 as of September 30, 2025 and arranging an additional private placement targeting about US$6,000,000 in gross proceeds.

Negative

  • Losses nearly doubled: Net loss increased by 98.3% to US$6,494,776 for the six months ended September 30, 2025 as expenses, particularly professional fees and growth investments, outpaced revenue gains.
  • Significant dilution and added commitments: Shares outstanding rose from 15,625,000 to 218,148,992 by September 30, 2025, with further shares issued for a US$10,700,000 acquisition and a planned 47,961,831-share private placement.

Insights

Revenue surged and capital was raised, but losses and dilution increased.

Garden Stage delivered rapid growth, with revenue rising from US$704,339 to US$3,401,178 for the six months ended September 30, 2025. Key drivers were introducing and referral income of US$1,625,075, stronger brokerage commissions, and a big jump in underwriting and placement income tied to a new bond placement. This indicates the core securities and referral businesses are scaling.

At the same time, expenses climbed from US$3,984,302 to US$9,888,208, led by professional fees of US$3,104,794, including a US$1,191,144 finder fee and US$1,458,674 of share-based compensation to consultants. Communications and technology and travel and business development also rose sharply. As a result, net loss widened to US$6,494,776, even though loss per share fell to US$0.11 on a much larger share base.

The company materially strengthened liquidity by raising US$14,752,687 from share issuance, lifting cash and restricted cash to US$18,961,800. It then agreed to acquire Mental Form (BVI) Limited for US$10,700,000, partly via US$5,000,000 cash and 35,625,000 shares at US$0.16, and arranged a January 2026 private placement of 47,961,831 Class A shares at US$0.1251 for about US$6,000,000 in gross proceeds. A shift to a dual-class structure with Class B shares carrying 100 votes each concentrates voting power and may affect future governance dynamics.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of January 2026

 

Commission File Number 001-41879

 

GARDEN STAGE LIMITED

(Translation of registrant’s name into English)

 

30/F, China Insurance Group Building
141 Des Voeux Road Central
Central, Hong Kong
Tel: +852 2688 6333

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

☒ Form 20-F     ☐ Form 40-F

 

 

 

Financial Statements and Exhibits.

 

The following exhibits are being filed herewith:

 

Exhibit No.   Description
99.1   Garden Stage Limited Announces Unaudited Financial Results for the First Half of Fiscal Year 2026

 

1

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: January 20, 2026 GARDEN STAGE LIMITED
     
  By: /s/ Sze Ho, CHAN
  Name:  Sze Ho, CHAN
  Title: Chief Executive Officer

 

2

 

Exhibit 99.1

 

Garden Stage Limited Announces Financial Results for the First Half of Fiscal Year 2026

 

Garden Stage Limited (“GSL” or the “Company”) (Nasdaq: GSIW) is an offshore holding company incorporated in the Cayman Islands with no material operations of its own. Through its Hong Kong operating entities, the Company engaged in providing securities dealing and brokerage services, underwriting and placement, and other financial services to a wide range of customers in Hong Kong and China. The Company today announced its unaudited financial results for the six months ended September 30, 2025 (“First Half 2026”).

 

First Half of Fiscal Year 2026 Financial Results

 

   For the Six Months Ended
September 30,
 
Selected Unaudited Interim Condensed Consolidated Statements of Income Data:   2025
USD
    2024
USD
    Change
%
 
Revenues   3,401,178    704,339    382.9 
Expenses   (9,888,208)   (3,984,302)   148.2 
Loss before income taxes   (6,487,030)   (3,279,963)   97.8 
Income tax (expense) benefits   (7,746)   5,238    (247.9)
Net loss   (6,494,776)   (3,274,725)   98.3 
Loss per share – basic and diluted   0.11    0.21    (47.6)

 

Revenues

 

Total revenues increased by 382.9% from US$704,339 for the six months ended September 30, 2024 to US$3,401,178 for the six months ended September 30, 2025. This increase was primarily attributable to higher revenue across most service lines, partially offset by lower due diligence service fees.

 

Advisory fees – Advisory fees increased by 100% from nil for six months ended September 30, 2024 to US$215,918 for six months ended September 30, 2025. The increase was primarily due to the rise in the number of engagements in advisory services from nil for six months ended September 30, 2024 to three for six months ended September 30, 2025.

 

Brokerage commissions – Brokerage commissions increased by 274.6% from US$163,374 for six months ended September 30, 2024 to US$611,965 for six months ended September 30, 2025. The increase was primarily attributed to heightened demand for securities brokerage activities in the U.S. market, resulting in higher trading volume on the exchanges in the U.S. during the six months ended September 30, 2025. In addition, brokerage commissions related to exchanges in Hong Kong also increased from US$130,591 for the six months ended September 30, 2024 to US$165,109 due to an increase in the number of active accounts and trading volume related to exchange in Hong Kong for the six months ended September 30, 2025.

 

Due diligence service fees – Due diligence service fees decreased by 100% from US$39,698 for the six months ended September 30, 2024, to nil for the six months ended September 30, 2025. We did not offer these services during the six months ended September 30, 2025, while we successfully onboarded two due diligence projects during the six months ended September 30, 2024.

 

Handling income – Handling income increased by 593.6% from US$44,480 for the six months ended September 30, 2024 to US$308,512 for the six months ended September 30, 2025. The increase was mainly driven by a higher handling income received from our custodian services for the six months ended September 30, 2025.

 

Introducing and referral income – Introducing and referral income increased significantly by 393.1% from US$329,534 for the six months ended September 30, 2024 to US$1,625,075 for the six months ended September 30, 2025. This substantial growth was primarily driven by higher referral income generated from our largest customer with whom we have maintained an active business relationship since January 2024.

 

 

 

Investment management fee income – Investment management fee income increased by 492.9% from US$7,826 for the six months ended September 30, 2024 to US$46,403 for the six months ended September 30, 2025. The increase was primarily due to a full six months of management fee income from an existing fund for the six months ended September 30, 2025, compared to only one month of income recorded for the six months ended September 30, 2024. In addition, there was a new fund managed by us since September 2025.

 

Underwriting and placement income – Underwriting and placement income increased significantly by 519.9% from US$82,251 for the six months ended September 30, 2024 to US$509,848 for the six months ended September 30, 2025. The increase was primarily due to a new bond placement, for which we acted as a placing agent and generated placement income amounted to US$473,193 for the six months ended September 30, 2025, while there was no such bond placement activity for the six months ended September 30, 2024.

 

Interest income and others – Interest income and others increased by 124.5% from US$37,176 for the six months ended September 30, 2024 to US$83,457 for the six months ended September 30, 2025. The increase was primarily due to a rise in interest income from customers on overdue receivables arising from brokerage transactions.

 

Expenses

 

Allowance for expected credit losses - Allowance for expected credit losses decreased from US$48,387 for the six months ended September 30, 2024 to US$25,950 for the six months ended September 30, 2025. The decrease in allowances was recognized to reflect changes in credit risk and prevailing economic conditions for the six months ended September 30, 2025.

 

Brokerage, clearing and exchange fees – Brokerage, clearing and exchange fees increased by 444.1% from US$300,745 for the six months ended September 30, 2024, to US$1,636,422 for the six months ended September 30, 2025. The increase was consistent with our increase in revenue from brokerage commissions and introducing and referral income.

 

Communications and technology – Communications and technology expenses increased by 126.0% from US$693,453 for the six months ended September 30, 2024 to US$1,567,372 for the six months ended September 30, 2025. The increase was mainly due to our effort to enhance operational efficiency through engaging an IT consultant to advance the IT operation systems, which aided in streamlining our daily operations.

 

Compensation and benefits – Compensation and benefits expenses increased by 16.0% from US$1,682,921 for the six months ended September 30, 2024 to US$1,952,889 for the six months ended September 30, 2025. The increase was primarily attributable to higher referral commissions to our staff, in line with our revenue growth, and a discretionary bonus to the head of investor relation and strategic planning for the six months ended September 2025. The increase was partially offset by a decrease in share-based compensation expenses, which declined from US$835,967 for the six months ended September 30, 2024 to US$527,582 for the six months ended September 30, 2025.

 

Depreciation – Depreciation expenses increased by 150.2% from US$14,578 for the six months ended September 30, 2024 to US$36,479 for the six months ended September 30, 2025. This increase resulted from a full six months of depreciation being recognized on the property and equipment acquired for our new office premises in July 2024, for the six months ended September 30, 2025. This compared to only three months of depreciation recognized on the same assets for the six months ended September 30, 2024.

 

Loss on disposal of property and equipment - Loss on disposal of property and equipment for the six months ended September 30, 2025 was nil, compared to US$15,291 for the six months ended September 30, 2024. No such loss was incurred during the six months ended September 30, 2025, while the loss for the six months ended September 30 2024 was related to the derecognition of leasehold improvements associated with our old office premises.

 

Occupancy costs – Occupancy costs decreased by 18.7% from US$92,826 for the six months ended September 30, 2024 to US$75,447 for the six months ended September 30, 2025, primarily due to the absence of a non-recurring two-month rental expenses incurred for the six months ended September 30, 2024, in respect of the Company’s old office premises.

 

Professional fees – Professional fees increased significantly by 875.1% from US$318,397 for the six months ended September 30, 2024 to US$3,104,794 for the six months ended September 30, 2025. The increase in professional fees was primarily due to finder fee on identifying a potential acquisition of US$1,191,144 and share based compensation expenses granted to the consultants in exchange for business review and development services of US$1,458,674, during the six months ended September 30, 2025. The share-based agreements were entered into in June 2025, accordingly, only four months of the costs were recognized for the six months ended September 30, 2025 while no such costs were recognized for the six months ended September 30, 2024.

 

2 

 

Travel and business development – Travel and business development expenses increased significantly by 92.7% from US$740,263 for the six months ended September 30, 2024 to US$1,426,560 for the six months ended September 30, 2025. The increase was primarily driven by continued investments in public relations and investor engagement, and fees for designing and executing a proactive investor relations program to enhance brand image and expand market visibility.

 

Other administrative expenses – Other administrative expenses decreased slightly from US$77,441 for the six months ended September 30, 2024 to US$62,295 for the six months ended September 30, 2025, primarily due to a drop in cost associated with office operation and company insurance premiums.

 

Loss before income taxes

 

We recorded a loss before income taxes of US$6,487,030 for the six months ended September 30, 2025, compared to US$3,279,963 for the six months ended September 30, 2024. The significant increase in loss before income taxes was primarily driven by an overall increase in expenses. Key contributing factors included higher professional fees and communications and technology expenses for the six months ended September 30, 2025.

 

Income tax (expenses) benefits

 

Income tax changed from income tax benefits of US$5,238 for the six months ended September 30, 2024 to income tax expenses of US$7,746 for the six months ended September 30, 2025. The change was primarily driven by an increase in current tax expenses related to the profits generated by our entities in Hong Kong and offset by the increased deferred tax assets related to temporary differences arising from the allowances for expected credit losses.

 

Although we incurred losses in both periods, income tax is presented as a net tax benefit for six months ended September 2024 and income tax expenses for the six months ended September 2025. Our effective tax rate is calculated as the income tax (expenses) benefit divided by loss before income tax. On this basis, our effective tax rate changed from 0.2% for the six months ended September 30, 2024 to (0.1)% for the six months ended September 30, 2025. This change in the effective tax rate primarily resulted from an increase in taxable profits generated by our entities in Hong Kong and the increase in non-deductible expenses incurred by our holding company, which increased our overall income tax expenses.

 

Net loss

 

As a result of the foregoing factors, net loss increased by 98.3% from US$3,274,725 for the six months ended September 30, 2024 to US$6,494,776 for the six months ended September 30, 2025.

 

Cash Flow

 

Net cash used in operating activities for the six months ended September 30, 2025 was US$3,412,709, as compared to the net loss of US$6,494,776. The difference was primarily attributable to (i) a decrease of US$2,268,674 in prepayments and other assets, which was attributed to the utilization of advance payments for IT and marketing services delivered; (ii) share based compensation expenses of US$1,986,256; (iii) an increase of US$3,072,958 in receivables from customers and an increase of US$3,170,862 in payables to customers, which was impacted by our customers’ fund allocation preferences of placing more cash with us in the designated accounts for their securities brokerage transactions; and (iv) an increase of US$1,738,660 in receivables from broker-dealers and clearing organizations and an increase of US$405,752 in payables to broker-dealers and clearing organizations, which were because there were more unsettled trades on trade-date basis related to exchange in Hong Kong and more cash being placed near the period end date September 30, 2025 as compared to year end date March 31, 2025, with our broker-dealers in relation to our customers’ securities dealing activities in the U.S. market.

 

3 

 

Net cash used in operating activities for the six months ended September 30, 2024 was US$809,604, as compared to the net loss of US$3,274,725. The difference was primarily attributable to (i) a decrease of US$1,242,619 in other assets, which was attributed to the utilization of advance payments for IT and marketing services delivered; (ii) share based compensation expenses of US$835,967; (iii) an increase of US$762,796 in receivables from customers and an increase of US$493,237 in payables to customers, which was impacted by our customers’ fund allocation preferences of placing more cash with us in the designated accounts for their securities brokerage transactions; and (iv) an increase of US$325,055 in receivables from broker-dealers and clearing organizations and an increase of US$902,154 in payables to broker-dealers and clearing organizations, which were because there were more unsettled trades on trade-date basis related to exchange in Hong Kong and more cash being placed near the period end date September 30, 2024 as compared to year end date March 31, 2024, with our broker-dealers in relation to our customers’ securities dealing activities.

 

Net cash used in investing activity for the six months ended September 30, 2025 and 2024 were nil and US$217,833, respectively. Net cash used in investing activity for the six months ended September 2024 was fully spent on the purchase of property and equipment.

 

Net cash provided by financing activities for the six months ended September 30, 2025 and 2024 was US$14,567,885 and nil, respectively. Net cash provided by financing activities for the six months ended September 30, 2025 represented proceeds from issuance of ordinary shares, net of issuance cost, of US$14,752,687, partially offset by repayments to related parties of US$184,802.

 

Recent events

 

On September 18, 2025, we held an extraordinary general meeting of shareholders at which the shareholders approved a proposal to change our authorized share capital from 500,000,000 ordinary shares of par value US$0.0001 each into (i) 490,750,000 Class A ordinary shares; and (ii) 9,250,000 Class B ordinary shares, each with a par value US$0.0001 each. Each Class A ordinary share shall entitle the holder to one vote on all matters subject to vote at our general meetings, and each Class B ordinary share shall entitle the holder to one hundred votes on all matters subject to vote at our general meetings. We are continuing to work with our counsel to implement this change, and the share redesignation has not yet taken effect as of the date of this Form 6-K.

 

On November 3, 2025, we entered into share purchase agreements with certain independent parties to acquire 100% of the equity interests in Mental Form (BVI) Limited, at an aggregate consideration of US$10,700,000. The consideration consisted of US$5,000,000 in cash and the issuance of 35,625,000 ordinary shares at a share price of US$0.16 per share, representing a non-cash consideration of US$5,700,000. The transaction was closed on November 18, 2025. Mental Form (BVI) Limited is a company incorporated in British Virgin Islands and principally engaged in selling humanoid robots and providing related services, and earning licensing fee income from related intellectual properties.

 

On January 12, 2026, we entered into securities purchase agreement with certain independent investors, pursuant to which we agreed to issue and sell, in a private placement offering (the “January 2026 Private Placement Offering”), 47,961,831 Class A ordinary shares with par value US$0.0001 per share, at a consideration of US$0.1251 per share for general corporate purposes. The investors have agreed to a 60-day lock-up restriction with us. The January 2026 Private Placement Offering is expected to close by the end of January 2026, and we would receive gross proceeds of approximately $6,000,000, before deducting estimated offering expenses.

 

4 

 

Garden Stage Limited

Unaudited Condensed Consolidated Balance Sheets
(Expressed in U.S. Dollars, except for the number of shares)

 

    As of  
    September 30,
2025
    March 31,
2025
 
    (Unaudited)     (Audited)  
Assets            
Current Assets                
Cash   $ 10,298,435     $ 624,583  
Restricted cash     8,663,365       7,261,041  
Receivables from broker-dealers and clearing organizations     2,853,284       1,108,468  
Receivables from customers, net     3,545,156       623,977  
Receivables from customers-related party, net     138,297       1,172  
Prepayments, current     5,973,691       4,143,218  
Other assets, current, net     36,218       10,524  
Total current assets     31,508,446       13,772,983  
                 
Non-current assets                
Operating lease right-of-use assets     137,192       185,684  
Deferred tax assets, net     32,948       23,909  
Property and equipment, net     128,167       164,847  
Intangible assets     64,244       64,268  
Prepayments, non-current     473,159       1,619,424  
Other assets, non-current, net     68,263       68,290  
Total non-current assets     903,973       2,126,422  
                 
Total assets   $ 32,412,419     $ 15,899,405  
                 
Liabilities and shareholders’ equity                
                 
Liabilities                
Current liabilities                
Payables to customers   $ 11,011,887     $ 8,019,375  
Payables to customers-related parties     363,557       176,367  
Payables to broker-dealers and clearing organizations     637,095       229,895  
Amounts due to related parties     74,461       260,064  
Income tax payable     71,917       63,901  
Operating lease liabilities, current     120,222       117,818  
Accrued expenses and other liabilities     258,781       248,298  
Total current liabilities     12,537,920       9,115,718  
                 
Non-current liabilities                
Operating lease liabilities, non-current     20,523       81,284  
Total non-current liabilities     20,523       81,284  
                 
Total liabilities     12,558,443       9,197,002  
                 
Commitments and contingencies     -       -  
                 
Shareholders’ equity                
Ordinary shares, $0.0001 par value, 500,000,000 shares authorized; 218,148,992 shares issued and outstanding as of September 30, 2025, 15,625,000 shares issued and outstanding as of March 31, 2025     21,815       1,563  
Additional paid-in capital     35,415,181       15,718,364  
Accumulated deficit     (15,481,391 )     (8,986,615 )
Accumulated other comprehensive losses     (101,629 )     (30,909 )
Total shareholders’ equity     19,853,976       6,702,403  
                 
Total liabilities and shareholders’ equity   $ 32,412,419     $ 15,899,405  

 

5 

 

Garden Stage Limited

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss
(Expressed in U.S. Dollars, except for the number of shares)

 

    For the Six Months Ended
September 30,
 
    2025     2024  
    (Unaudited)     (Unaudited)  
Revenues                
Advisory fees   $ 215,918     $ -  
Brokerage commissions     608,997       151,452  
Brokerage commissions-related parties     2,968       11,922  
Due diligence services fees     -       39,698  
Handling income     308,448       44,480  
Handling income-related parties     64       -  
Introducing and referral income     1,625,075       329,534  
Investment management fee income     39,554       7,826  
Investment management fee income-related parties     6,849       -  
Underwriting and placement income     509,848       82,251  
Interest income and others     82,796       35,157  
Interest income and others-related parties     661       2,019  
Total revenues     3,401,178       704,339  
Expenses                
Allowance for expected credit losses     25,950       48,387  
Brokerage, clearing and exchange fees     1,636,422       300,745  
Communications and technology     1,567,372       693,453  
Compensation and benefits     1,952,889       1,682,921  
Deprecation     36,479       14,578  
Loss on disposal property and equipment     -       15,291  
Occupancy costs     75,447       92,826  
Professional fees     3,104,794       318,397  
Travel and business development     1,426,560       740,263  
Other administrative expenses     62,295       77,441  
Total expenses     9,888,208       3,984,302  
                 
Loss before income taxes     (6,487,030 )     (3,279,963 )
Income tax (expenses) benefits     (7,746 )     5,238  
Net loss     (6,494,776 )     (3,274,725 )
                 
Other comprehensive (loss) income                
Foreign currency translation adjustments     (70,720 )     48,346  
Total comprehensive loss   $ (6,565,496 )   $ (3,226,379 )
                 
Loss per share:                
Basic and diluted   $ 0.11     $ 0.21  
                 
Weighted average number of ordinary shares outstanding:                
Ordinary shares – Basic and diluted     57,521,728       15,625,000  

 

6 

 

Garden Stage Limited
Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Equity
(Expressed in U.S. Dollars, except for the number of shares)

 

Six months ended September 30, 2024

 

   Ordinary shares   Additional       Accumulated
other
     
    Number
issued
    Amount    paid-in
capital
    Accumulated
deficit
    comprehensive
loss
    Total 
Balance as of March 31, 2024 (Audited)   15,625,000   $1,563   $14,033,722   $(4,668,973)  $(80,824)  $9,285,488 
Net loss   -    -    -    (3,274,725)   -    (3,274,725)
Share based awards   -    -    842,321    -    -    842,321 
Foreign currency translation adjustments   -    -    -    -    48,346    48,346 
Balance as of September 30, 2024 (Unaudited)   15,625,000   $1,563   $14,876,043   $(7,943,698)  $(32,478)  $6,901,430 

 

Six months ended September 30, 2025

 

   Ordinary shares   Additional       Accumulated
other
     
    Number
issued
    Amount    paid-in
capital
    Accumulated
deficit
    comprehensive
loss
    Total 
Balance as of March 31, 2025 (Audited)   15,625,000   $1,563   $15,718,364   $(8,986,615)  $(30,909)  $6,702,403 
Issuance of ordinary shares, net of issuance costs   196,623,992    19,662    14,733,025    -    -    14,752,687 
Net loss   -    -    -    (6,494,776)   -    (6,494,776)
Share based awards   5,900,000    590    4,963,792    -    -    4,964,382 
Foreign currency translation adjustments   -    -    -    -    (70,720)   (70,720)
Balance as of September 30, 2025 (Unaudited)   218,148,992   $21,815   $35,415,181   $(15,481,391)  $(101,629)  $19,853,976 

 

 

7 

 

Garden Stage Limited
Unaudited Condensed Consolidated Statements of Cash Flows
(Expressed in U.S. dollar)

  

   For the Six Months Ended
September 30,
 
   2025   2024 
   (Unaudited)   (Unaudited) 
Cash flows from operating activities:          
Net loss  $(6,494,776)  $(3,274,725)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation   36,479    14,578 
Allowance for expected credit losses   25,950    48,387 
Amortization of operating lease right-of-use assets and interest of lease liabilities   51,619    53,950 
Loss on disposal of property and equipment   -    15,291 
Share based compensation expenses   1,986,256    835,967 
Deferred tax benefits   (9,015)   (5,721)
Change in operating assets and liabilities:          
Receivables from broker-dealers and clearing organizations   (1,738,660)   (325,055)
Receivables from customers, net   (3,072,958)   (762,796)
Prepayments and other assets, net   2,268,674    1,242,619 
Payables to customers   3,170,862    493,237 
Payables to broker-dealers and clearing organizations   405,752    902,154 
Operating lease liabilities   (61,441)   (40,979)
Income tax payable   8,010    483 
Accrued expenses and other liabilities   10,539    (6,994)
Net cash used in operating activities   (3,412,709)   (809,604)
           
Cash flows from investing activity:          
Purchases of property and equipment       (217,833)
Net cash used in investing activity       (217,833)
           
Cash flows from financing activities:          
Proceeds from issuance of ordinary shares, net of issuance costs   14,752,687     
Repayment to related parties   (184,802)    
Net cash provided by financing activities   14,567,885     
           
Effect of exchange rate changes on cash and restricted cash   (79,000)   59,294 
Net increase (decrease) in cash and restricted cash   11,076,176    (968,143)
Cash and restricted cash, beginning of period   7,885,624    8,938,202 
Cash and restricted cash, end of period   18,961,800    7,970,059 
           
Reconciliation of cash and restricted cash to the consolidated balance sheets          
Cash  $10,298,435   $863,069 
Restricted cash   8,663,365    7,106,990 
Total cash and restricted cash  $18,961,800   $7,970,059 
           
Supplemental non-cash financing activities          
Issuance costs charged to additional paid in capital  $512,976   $ 
           
Supplemental disclosures of cash flow information:          
Cash paid for taxes, net  $8,783   $ 

 

8 

 

FAQ

How did Garden Stage Limited (GSIW) perform in the first half of fiscal 2026?

For the six months ended September 30, 2025, Garden Stage Limited reported revenue of US$3,401,178, up sharply from US$704,339 a year earlier. Net loss widened to US$6,494,776 from US$3,274,725, reflecting much higher professional fees, technology spending, and business development costs.

What were the main drivers of revenue growth for Garden Stage Limited (GSIW)?

Revenue growth came mainly from introducing and referral income, which rose to US$1,625,075, stronger brokerage commissions of US$611,965, higher underwriting and placement income of US$509,848 tied to a new bond placement, and new streams such as advisory fees of US$215,918 and higher investment management fees.

Why did Garden Stage Limiteds net loss increase despite higher revenue?

Total expenses increased from US$3,984,302 to US$9,888,208. Key factors were a jump in professional fees to US$3,104,794, including a finder fee and share-based compensation to consultants, higher communications and technology expenses of US$1,567,372, and higher travel and business development costs of US$1,426,560, which together more than offset the revenue gains.

What capital-raising activities did Garden Stage Limited (GSIW) undertake?

The company raised US$14,752,687 in net proceeds from issuing ordinary shares during the six months ended September 30, 2025, increasing total shareholders equity to US$19,853,976. It also entered into a January 2026 private placement agreement to issue 47,961,831 Class A ordinary shares at US$0.1251 per share, targeting approximately US$6,000,000 in gross proceeds.

What acquisition did Garden Stage Limited announce in this 6-K filing?

On November 3, 2025, Garden Stage Limited agreed to acquire Mental Form (BVI) Limited for aggregate consideration of US$10,700,000, consisting of US$5,000,000 in cash and the issuance of 35,625,000 ordinary shares at US$0.16 per share. The deal closed on November 18, 2025, adding a business that sells humanoid robots, provides related services, and earns licensing fee income.

How did Garden Stage Limiteds balance sheet change as of September 30, 2025?

Total assets increased to US$32,412,419 from US$15,899,405 at March 31, 2025, largely due to higher cash and restricted cash, which rose to US$18,961,800. Total liabilities increased to US$12,558,443, while shareholders equity grew to US$19,853,976, reflecting the sizable equity issuance and accumulated losses.

What governance changes did Garden Stage Limited shareholders approve?

On September 18, 2025, shareholders approved changing the authorized share capital from 500,000,000 ordinary shares into 490,750,000 Class A ordinary shares and 9,250,000 Class B ordinary shares. Each Class A share carries one vote, while each Class B share carries 100 votes on matters at general meetings. The company is working with counsel to implement this change.

Garden Stage Ltd.

NASDAQ:GSIW

GSIW Rankings

GSIW Latest News

GSIW Latest SEC Filings

GSIW Stock Data

34.18M
200.83M
42.61%
9.79%
7.35%
Capital Markets
Financial Services
Link
Hong Kong
Central